Uncover Top Australian Weight Loss Peptides & Natural Supplements

Here at weight loss supps we are expanding our range of research chemical peptides and two of the recent additions ate BPC-157 and TB50...

A new weight-loss drug dubbed the 'triple G' could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric s...

SAN DIEGO — An experimental drug from Eli Lilly has the potential to provide greater weight loss benefits than any drug currently ...

It’s unclear when retatrutide will be available in the UK or the U.S. It’s likely it won’t be available for several years, with 2028 being the earliest possible date

Retatrutide also appears to support more significant weight loss than Ozempic. Research suggests that Ozempic supports an average weight loss of around 6 kg after 40 weeks. On retatrutide, it’s closer to 20kg.

Retatrutide and tirzepatide are different drugs with different chemical compositions. While retatrutide mimics three hormones to support weight loss, tirzepatide mimics two.

In 2023, a randomised controlled trial on 338 participants showed that retatrutide supported an average weight loss of 24% after 48 weeks. If you weighed 100 kg, this would be a weight loss of 24kg.